SearchDictionaryMobileLogin

Oligoclonal Bands

555  relevant articles (11 outcomes, 27 trials/studies) found for this Bio-Agent

Description: Multiple protein bands serving as markers of specific ANTIBODIES and detected by ELECTROPHORESIS of CEREBROSPINAL FLUID or serum. The bands are most often seen during inflammatory or immune processes and are found in most patients with MULTIPLE SCLEROSIS.

Also Known As:
Oligoclonal IgG; Oligoclonal IgM; Bands, Oligoclonal; IgG, Oligoclonal; IgM, Oligoclonal; Immunoglobulins, Oligoclonal; Oligoclonal Immunoglobulins

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Itoyama, Y: 3 articles (04/2007 - 12/2002)
2. Nakashima, I: 3 articles (04/2007 - 12/2002)
3. Sato, S: 3 articles (04/2007 - 12/2002)
4. Fujihara, K: 3 articles (04/2007 - 12/2002)
5. Teelken, A: 2 articles (04/2008 - 07/2007)
6. Koch, M: 2 articles (04/2008 - 07/2007)
7. De Keyser, J: 2 articles (04/2008 - 07/2007)
8. Heersema, D: 2 articles (04/2008 - 07/2007)
9. Mostert, J: 2 articles (04/2008 - 07/2007)
10. Rovira, A: 2 articles (03/2008 - 12/2001)

Related Diseases

1. Multiple Sclerosis
2. Leukocytosis (Pleocytosis)
3. Measles
4. Transverse Myelitis (Necrotizing Myelitis)
5. Myelitis
08/01/1993 - "GFAP-specific oligoclonal bands in the CSF of a patient with acute myelitis."
08/01/1993 - "The specificity for GFAP (glial fibrillary acidic protein) of oligoclonal IgG bands in the CSF of a patient with acute myelitis was demonstrated by isoelectric focusing and affinity blotting. "
07/01/1990 - "It is recommended that, before the diagnosis of MS is changed to that of HTLV-I-associated chronic myelitis, at least 2 of the following abnormalities be present: (1) clinical or electrophysiologic involvement of peripheral nerve or muscle; (2) the presence of oligoclonal bands in the serum; (3) the presence in blood or CSF of lymphocytes with multilobed nuclei; (4) a positive serologic test for syphilis; (5) the presence of a sicca syndrome; and (6) the presence of pulmonary lymphocytic alveolitis."
06/01/1979 - "oligoclonal bands and/or regional increases of gamma-globulins, were more frequent in patients with (meningo-)encephalitic or (meningo-)-myelitis/radiculitic disorders (respectively 69 and 48%) than in subjects with meningitis or Guillain-Barré syndrome (17%). "
11/01/2007 - "Recurrent NMO has been described as optic-spinal multiple sclerosis (OSMS) in Japan, but it has been known that NMO has distinct clinical and laboratory findings (female preponderance, severe disability, longitudinally extensive myelitis, CSF-pleocytosis, negative oligoclonal IgG bands, etc) from those in typical MS. In addition, anti-aquaporin-4 (AQP4) antibody and loss of AQP4 in the active perivascular NMO lesions with deposition of immunoglobulins and activated complements were recently found to be NMO-specific, strongly suggesting that NMO is a clinical entity that should be separated from MS. In accordance with these unique features of NMO, different therapeutic responses between NMO and MS have been observed, that is, interferon-beta, a disease-modifying therapy (DMT) for MS, is less effective in NMO, while long-term administration of corticosteroid and immunosuppressive agents reduce relapses of NMO. "
Order ALL the reference details at left...

Related Drugs and Biologics

1. Immunoglobulin G (IgG)
2. Antibodies
3. Proteins (Proteins, Gene)
4. Sepharose (Agarose)
5. Immunoglobulins (Immunoglobulin)
6. Immunoglobulin A (IgA)
7. Cyclophosphamide (Cytoxan)
8. Adrenal Cortex Hormones (Corticosteroids)
9. Interferon-beta
10. Immunosuppressive Agents (Immunosuppressants)

Related Therapies and Procedures

1. Plasmapheresis
2. Drug Therapy (Chemotherapy)
3. Thymectomy
4. Transplantation (Transplant Recipients)

Best Treatments:
Research Summary Report
on Multiple Sclerosis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 519 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>